CLYM - Climb Bio, Inc.
1.2
-0.050 -4.167%
Share volume: 109,296
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.25
-0.05
-0.04%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2024 | 08-10-2023 | 11-14-2023 | 11-12-2024 | 05-15-2024 | 08-14-2024 | 11-12-2024 | 03-25-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 23.438 M | 6.714 M | 5.001 M | 5.122 M | 3.005 M | 56.372 M | 11.732 M | 10.911 M | |
| Selling general and admin | 17.718 M | 3.026 M | 2.125 M | 1.995 M | 1.914 M | 3.667 M | 5.492 M | 4.952 M | |
| Research and development | 5.720 M | 3.688 M | 2.876 M | 3.127 M | 1.091 M | 52.705 M | 6.240 M | 5.959 M | |
| Total expenses | 23.438 M | 6.714 M | 5.001 M | 5.122 M | 3.005 M | 56.372 M | 11.732 M | 10.911 M | |
| -71.35% | -25.51% | 2.42% | -41.33% | 1,775.94% | -79.19% | -7.00% | |||
| Operating income | -23.438 M | -6.714 M | -5.001 M | -5.122 M | -3.005 M | -56.372 M | -11.732 M | -10.911 M | |
| Ebit | -23.438 M | -6.714 M | -5.001 M | -5.122 M | -3.005 M | -54.889 M | -8.947 M | -10.911 M | |
| Pretax income | -22.290 M | -5.220 M | -3.968 M | -3.641 M | -1.697 M | -54.889 M | -8.947 M | -8.364 M | |
| -76.58% | -23.98% | -8.24% | -53.39% | 3,134.47% | -83.70% | -6.52% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -22.290 M | -5.220 M | -3.968 M | -3.641 M | -1.697 M | -54.889 M | -8.895 M | -8.416 M | |
| 76.58% | 23.98% | 8.24% | 53.39% | -3,134.47% | 83.79% | 5.39% |
